Business
WEX is a global commerce platform that provides seamlessly embedded, personalized payments solutions across three business segments: Mobility, Benefits, and Corporate Payments.
WEX Inc.: Revenue declined 1.2% to $1.845B from $1.867B. Net income declined 1.8% to $304.1M from $309.6M. Free cash flow declined 6.1% to $313.7M from $334.1M. Operating margin contracted 77 bps to 35.98%. WEX Inc.'s principal statistical and annual-change screens add no overriding warning to the reported profit and cash-flow record.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 1.2%Watch
- Profitability — Net income declined 1.8% to $304.1M from $309.6MWatch
- Cash flow — Free cash flow declined 6.1% to $313.7M from $334.1MWatch
- Margins — Operating margin contracted 77 bps to 35.98%Watch
- Accounting — No overriding statistical warningNote
- Insiders — 2 purchases and 14 salesOK
Where the revenue comes from
Fiscal 2025, as WEX Inc. reports it. History and quarterly detail are in the app.
- Mobility$1.4B
- Benefits$797.4M
- Corporate Payments$477.4M
Leadership changes
From WEX Inc.'s own filings, the day they're filed.
- Aimee Cardwell · Director · appointment
- David Foss · Director · departure
Latest filings
- 10-Q · Quarterly report2026-07-23
- 8-K · Company announcement2026-07-22
- 8-K · Company announcement2026-05-14
- 8-K · Company announcement2026-05-04
- 10-Q · Quarterly report2026-04-23
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about WEX Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.